| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT07409428 A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory… |
Trial sites expanded: 41 -> 50 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-22 | NCT07718581 HMPL-A830 in Solid Tumors | Phase 1/2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06584032 | Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer | Advanced Endometrial Cancer | Recruiting |
| NCT06387069 | A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia | Acute Myeloid Leukemia | Recruiting |
| NCT07409428 | A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory… | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Recruiting |
| Phase 2/3 | |||
| NCT04353375 | HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma | Advanced Intrahepatic Cholangiocarcinoma | Recruiting |
| NCT06361888 | A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With… | Metastatic Pancreatic Cancer | Recruiting |
| NCT05522231 | Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell… | Advanced Renal Cell Carcinoma | Active, Not Recruiting |
| NCT05535933 | HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia | Warm Antibody Autoimmune Hemolytic Anemia | Active, Not Recruiting |
| Phase 2 | |||
| NCT06601504 | Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07396584 | HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor | Solid Tumors, Adult | Recruiting |
| NCT07228247 | A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic… | Solid Tumors, Adult | Recruiting |
| NCT07718581 | HMPL-A830 in Solid Tumors | Solid Tumor, Adult | Not Yet Recruiting |
| Phase 1 | |||
| NCT07025018 | Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations | Gliomas Harboring IDH1 and/or IDH2 Mutations | Recruiting |
| NCT06387082 | A Clinical Study of HMPL-506 in Patients With Hematological Malignancies | Hematological Malignancies | Recruiting |
| NCT07643272 | A Study on the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of… | Healthy Participants | Active, Not Recruiting |